Skip to search formSkip to main contentSkip to account menu

lobenzarit

Known as: lobenzart, 2-((2-carboxyphenyl)amino)-4-chlorobenzoic acid, Benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Anti-Inflammatory Agents, Non-SteroidalImmunologic AdjuvantsImmunosuppressive Agentsortho-Aminobenzoates

Narrower (1)

lobenzarit disodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Gigantomastia induced by bucillamine.
Drug-induced mammary hyperplasias have been reported as rare complications of D-penicillamine and Neothetazone. The authors… 
1996
1996
Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: The regulation of lymph node cell populations and cytokine production
A single dose of either cyclosporin-A (CsA) or lobenzarit (CCA) given with an arthrogenic adjuvant completely prevented… 
Highly Cited
1995
Highly Cited
1995
Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis.
1994
1994
Treatment of systemic lupus erythematosus with lobenzarit: an open clinical trial.
An open clinical trial was designed to examine the efficacy and safety of lobenzarit (CCA), a newly developed disease modifying… 
1993
1993
Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
OBJECTIVE The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus… 
1992
1992
Effects of lobenzarit on murine acute viral myocarditis
SummaryLobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number… 
1991
1991
Suppressive effect of anti-rheumatic drugs on interleukin-1 beta release from human peripheral blood monocytes.
1989
1989
Different inhibitory actions of immunomodulating agents and immunosuppressive agents on bone resorption of mouse calvaria.
1989
1989
Inhibition of Streptozocin-Induced Insulitis and Diabetes With Lobenzarit in CD-1 Mice
When multiple low doses (30 mg/kg body wt) of streptozocin were given to CD-1 mice, diabetes associated with L3T4 T-lymphocyte… 
1984
1984
A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis.
A multicenter double-blind study was carried out in patients with rheumatoid arthritis (RA) by comparing treatment with a novel… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)